| Prev Close | 2.23 |
| Day Low/High | 2.22 / 2.27 |
| 52 Wk Low/High | 2.21 / 8.77 |
| Avg Volume | 36.05M |
| Exchange | NYSE |
| Shares Outstanding | 1.05B |
| Market Cap | 2.35B |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
Cisco Disappoints as Tech Lags; Walgreens-Rite Aid Test FTC Again -- ICYMI
Here's what you need to know now for Thursday, August 17.
Walgreens Tries to Avoid Another FTC Ordeal
The much smaller asset purchase they are now attempting should not raise the kinds of concerns the commission had about the original merger, they argue.
RediClinic Makes Back-to-School Physical Exams And Vaccinations Fast, Easy, Convenient And Affordable
RediClinic, a leading operator of convenient care clinics, is offering back-to-school physical exams and vaccinations in all locations, helping busy parents and students meet school requirements for vaccinations and good...
Walgreens Takes Piece of PharMerica, Quest to Dominate Healthcare Continues
The deal is worth $1.4 billion and PharMerica's board has already given it the green light.
Get Back-to-School Ready At Rite Aid
School bells will soon be ringing, signaling the start of a new school year and the second-busiest shopping season, according to the National Retail Federation.
Seasonal Flu Shots Now Available At Rite Aid
In an effort to help patients looking to protect themselves against the flu, Rite Aid announced today the availability of seasonal flu shots at Rite Aid pharmacies across the country.
Walgreens Could Face Amazon Challenge; Plus an Update on Facebook, Cisco and Comcast
Updating members on a few other items that we are keeping an eye on.
Cramer: Amazon's Shadow Over Retail Continues to Spread
No one knows where the giant squid is going to strike next.
If It's Not Earnings News, It's Amazon Competition: Jim Cramer's Best Blog
Stock prices are either unfairly dragged down by competitors' earnings news or by Amazon's spread into more businesses, Cramer said.
Weekly Roundup
Earnings help boost markets as D.C. isn't counted on for much of anything. Portfolio action (it was a busy week) includes a new position and a downgrade.
Rite Aid Expands Naloxone Dispensing Program To Michigan And South Carolina
Rite Aid announced today that naloxone, a medication that can be used to reverse the effects of an opioid overdose, is now available at more than 360 pharmacies in Michigan and South Carolina without a prescription, subject...
Exiting This Healthcare Name
We're selling our shares in Walgreens as our bullish thesis has lost its luster.
Weekly Roundup
The market surged this week as positive earnings and a mellower tone from Janet Yellen cheered bulls.
Tesla's Rally Has Died: Stock Falls to Sixth Worst Performer in Russell 1000
It was the seventh best performer in the index during the first half of the year.
Hey Walgreens and Rite Aid, Look at These Two Deals the Government Just Said Are Cool
The chess game continues.
Weekly Roundup
Jobs report and Fed minutes highlight a short week. In the portfolio, we add one name and downgrade another.
Biotech Movers: Immuno-Oncology Pact With Celgene Sends BeiGene Shares Soaring
BeiGene and Impax Laboratories were among the biotech movers in premarket trading on July 6.
Here's Why Amazon Could Feast on the Remaining Carcass of Rite Aid After Failed Walgreens Merger
One Wall Street firm thinks it's a real possibility.
Biotech Movers: BioCryst, Omeros, Radius Health
BioCryst Pharmaceuticals, Omeros and Radius Health were among the were among the biotech stock movers in premarket trading on July 3.
Your Obsession With Apple, Android and Samsung Smartphones Could Be Making You Chronically Tired
Oxford sleep researcher Russell Foster argues that smartphone addiction is compromising the sleep time an average teenager is getting.
Tesla Is Quietly Building a Monopoly?
Analysts at Berenberg say traditional automakers remain complacent about electric vehicles.
Uber Surpasses 5 Billion Trips
Uber thanked the dedication of the drivers making those trips possible and awarded each $500.
McDonald's New Use of Machines Is Great for Its Stock Price
The firm expects the company to lower its labor costs and increase sales.
Take a Look at These New Defibrillator Drones -- They Could Save Your Life Someday
Drones to the rescue!
